Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2100061	注射用贝林妥欧单抗	blinatumomab	Lyophilized	Biological Products(3.1)	Supplementary Application	2021-02-26	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	In Review	2022-01-27	view
JXSS2100020	注射用贝林妥欧单抗	blinatumomab	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-03-31	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	In Review	2021-03-30	view
JYSB2300008	注射用贝林妥欧单抗	blinatumomab	Lyophilized	Biological Products	Supplementary Application	2023-01-14					view
JYSB2200192	注射用贝林妥欧单抗	blinatumomab	Lyophilized	Biological Products	Supplementary Application	2022-10-11					view